Immunization News and Research

RSS

Vaccine hesitancy is not a barrier to vaccination efforts, says study

A team of researchers from the USA, Germany and Norway recently found that the main barrier to vaccination is not vaccine hesitancy but a supply shortage and unequal distribution of the vaccines themselves.

30 Apr 2021

Study develops COVID-19 pandemic reopening strategies in California

A working paper from researchers at the RAND corporation explores the various options to come up with a proposed robust plan for reopening up regions where vaccines have not yet been deployed across the entire population.

30 Apr 2021

Government mistrust plays a vital role in slowing down child vaccination progress in Africa

Mistrust in local and national government plays a significant role in slowing down child vaccination progress in Africa - the continent home to half of the world's unvaccinated and under-vaccinated children, new research reveals.

30 Apr 2021

Study: More than a quarter of American infants not received common childhood vaccines

More than a quarter of American infants in 2018 had not received common childhood vaccines that protect them from illnesses such as polio, tetanus, measles, mumps and chicken pox, new research from the University of Virginia School of Medicine reveals.

29 Apr 2021

A ‘dose of hope’? Fact-checking President Joe Biden’s first speech to Congress

In his first speech before Congress, President Joe Biden argued it was time to turn the coronavirus pandemic into a historic opportunity to expand government for the benefit of a wider range of Americans, urging investments in jobs, climate change, child care, infrastructure and more.

29 Apr 2021

Study of 180 breastfeeding mothers after mRNA COVID-19 vaccination

Vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19, were developed at an unprecedented pace. To date, more than 1 billion vaccine doses have been administered worldwide, many of which messenger RNA (mRNA) based.

29 Apr 2021

Safety and efficacy of Pfizer and AstraZeneca COVID-19 vaccines even better than clinical trials predicted

Researchers in the UK and United States have demonstrated the efficacy of one dose of either the Pfizer-BioNTech or Oxford-AstraZeneca vaccine against infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a real-world community setting in the UK.

28 Apr 2021

You don’t have to suffer to benefit from Covid vaccination — but some prefer it

If you think vaccination is an ordeal now, consider the 18th-century version. After having pus from a smallpox boil scratched into your arm, you would be subject to three weeks of fever, sweats, chills, bleeding and purging with dangerous medicines, accompanied by hymns, prayers and hell-fire sermons by dour preachers.

28 Apr 2021

Pfizer-BioNTech (BNT162b2) vaccine successfully curbs COVID-19 in Israel

Researchers in Israel have shown that three national programs established by the Israeli government have successfully reduced cases of severe coronavirus disease 2019 (COVID-19) and death caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

27 Apr 2021

U-M study finds low HPV vaccination rate among young adult men in the U.S.

The COVID-19 vaccine isn't having any trouble attracting suitors. But there's another, older model that's been mostly ignored by the young men of America: the HPV vaccine.

27 Apr 2021

Nucleocapsid-based vaccines may prevent SARS-CoV-2 dissemination to distal organs

A team of scientists recently investigated and compared the efficacy of spike-based and nucleocapsid-based COVID-19 vaccines in mice infected with SARS-CoV-2. Their findings reveal that nucleocapsid-based vaccines are effective in preventing SARS-CoV-2 infection in distal organs, such as the brain.

27 Apr 2021

World Immunization Week: Vaccination in 2021

News-Medical talks to experts in different areas of the medical sector on why immunization week is so prevalent in 2021.

27 Apr 2021

Nanobodies neutralize SARS-CoV-2 in pre-clinical model

A team of Australian researchers at the Walter and Eliza Hall Institute of Medical Research (WEHI), the Doherty Institute, and the Kirby Institute have identified neutralizing nanobody cocktails that block the SARS-CoV-2 virus from entering cells in pre-clinical models.

27 Apr 2021

Prior SARS-CoV-2 infection and Pfizer-BioNTech’s COVID-19 vaccine provide similar immunity

Researchers in Israel have conducted a study showing that the immunity provided against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease (COVID-19) – is similar following natural infection or immunization with the Pfizer-BioNTech BNT162b2 vaccine.

26 Apr 2021

Study to evaluate how people with immune system deficiencies respond to COVID-19 vaccination

A study assessing how people with immune system deficiencies or dysregulations respond to COVID-19 vaccination has begun enrolling participants at the National Institutes of Health Clinical Center in Bethesda, Maryland.

26 Apr 2021

A detailed look at two cases of symptomatic COVID in vaccinated individuals

In a recent brief report published in the prestigious New England Journal of Medicine, researchers from the Rockefeller University in New York described a case of two fully vaccinated individuals in whom they found subsequent breakthrough infections with variants of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), carrying a number of substitutions of interest.

25 Apr 2021

FDA, CDC lift recommended pause on the use of Janssen COVID-19 vaccine in the U.S.

Following a thorough safety review, including two meetings of the CDC's Advisory Committee on Immunization Practices, the U.S. Food and Drug Administration and the U.S. Centers for Disease Control and Prevention have determined that the recommended pause regarding the use of the Johnson & Johnson (Janssen) COVID-19 Vaccine in the U.S. should be lifted and use of the vaccine should resume.

23 Apr 2021

Disruptions to essential health services due to COVID-19 pandemic persist in 90% of countries

The second round of a World Health Organization "pulse survey" reveals that over one year into the COVID-19 pandemic, substantial disruptions persist, with about 90% of countries still reporting one or more disruptions to essential health services, marking no substantial global change since the first survey conducted in the summer of 2020.

23 Apr 2021

World Malaria Day 2021: An interview with Sir Brian Greenwood

News-Medical interviews Sir Brian Greenwood about raising awareness for malaria during the COVID-19 pandemic and achieving elimination of the disease.

23 Apr 2021

DNA vaccine candidate induces potent immunity, offers protective efficacy in non-human primate models

A synthetic DNA vaccine candidate for Middle East respiratory syndrome coronavirus (MERS-CoV) developed at The Wistar Institute induced potent immune responses and afforded protective efficacy in non-human primate (NHP) models when given intradermally in abbreviated, low-dose immunization regimen.

23 Apr 2021

Immunization News and Research

Vaccine hesitancy is not a barrier to vaccination efforts, says study

Study develops COVID-19 pandemic reopening strategies in California

Government mistrust plays a vital role in slowing down child vaccination progress in Africa

Study: More than a quarter of American infants not received common childhood vaccines

A ‘dose of hope’? Fact-checking President Joe Biden’s first speech to Congress

Study of 180 breastfeeding mothers after mRNA COVID-19 vaccination

Safety and efficacy of Pfizer and AstraZeneca COVID-19 vaccines even better than clinical trials predicted

You don’t have to suffer to benefit from Covid vaccination — but some prefer it

Pfizer-BioNTech (BNT162b2) vaccine successfully curbs COVID-19 in Israel

U-M study finds low HPV vaccination rate among young adult men in the U.S.

Nucleocapsid-based vaccines may prevent SARS-CoV-2 dissemination to distal organs

World Immunization Week: Vaccination in 2021

Nanobodies neutralize SARS-CoV-2 in pre-clinical model

Prior SARS-CoV-2 infection and Pfizer-BioNTech’s COVID-19 vaccine provide similar immunity

Study to evaluate how people with immune system deficiencies respond to COVID-19 vaccination

A detailed look at two cases of symptomatic COVID in vaccinated individuals

FDA, CDC lift recommended pause on the use of Janssen COVID-19 vaccine in the U.S.

Disruptions to essential health services due to COVID-19 pandemic persist in 90% of countries

World Malaria Day 2021: An interview with Sir Brian Greenwood

DNA vaccine candidate induces potent immunity, offers protective efficacy in non-human primate models

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News